Skip to main content
OpenTrials

Clinical trial condition

Hemangioendothelioma, Epithelioid

Explore clinical trials studying Hemangioendothelioma, Epithelioid. Study availability and eligibility vary by location and protocol.

12 public trials 5 recruiting studies
Refine in advanced search Browse all conditions

Hemangioendothelioma, Epithelioid trial results

Recruiting

NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)

NCT06239272

Conditions
Adipocytic Neoplasm, Angiomatoid Fibrous Histiocytoma, Angiosarcoma, +60 more
Locations
  • Children's Healthcare of Atlanta Atlanta, Georgia, United States
  • Lurie Children's Hospital of Chicago Chicago, Illinois, United States
  • Our Lady of the Lake Children's Hospital Baton Rouge, Louisiana, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Recruiting

SARC046: A Phase II Trial of Nab-Sirolimus in Patients With Progressing or Symptomatic Epithelioid Hemangioendothelioma

NCT07104331

Conditions
Epithelioid Hemangioendothelioma (EHE), Hemangioendothelioma, Hemangioendothelioma, Epithelioid, +4 more
Locations
  • Stanford University Stanford, California, United States
  • University of Colorado Aurora, Colorado, United States
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Recruiting

The Epithelioid Hemangioendothelioma Registry of the European Reference Network on Rare Adult Solid Cancers (EURACAN)

NCT06408441

Conditions
Epithelioid Hemangioendothelioma, Hemangioendothelioma, Hemangioendothelioma, Epithelioid, +7 more
Locations
  • University Hospital Graz Graz, Austria
  • Aarhus University Hospital Aarhus, Denmark
  • Léon Bérard Center Lyon, France
  • Centre Oscar Lambret Lille, France
View all 22 locations
View Trial Details
Recruiting

Multimodal Immune Characterization of RAre Soft Tissue Sarcoma - MIRAS Project From SARRA (SARcome RAre) Project of the French Sarcoma Group

NCT03967834

Conditions
Alveolar Soft Part Sarcoma, Clear Cell Sarcoma, Desmoplastic Small Round Cell Tumor, +19 more
Locations
  • Chu Besancon - Site Jean Minjoz Besançon, France
  • Institut Bergonié Bordeaux, France
  • Centre Jean Perrin Clermont-Ferrand, France
  • Centre Georges François Leclerc Dijon, France
View all 20 locations
View Trial Details
Completed

Trametinib in Treating Patients With Epithelioid Hemangioendothelioma That is Metastatic, Locally Advanced, or Cannot Be Removed by Surgery

NCT03148275

Conditions
Hemangioendothelioma, Hemangioendothelioma, Epithelioid, Hemangioma, +6 more
Locations
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Stanford Cancer Institute Palo Alto Palo Alto, California, United States
  • UCHealth University of Colorado Hospital Aurora, Colorado, United States
View all 36 locations
View Trial Details
Completed

Trial of Sunitinib and/or Nivolumab Plus Chemotherapy in Advanced Soft Tissue and Bone Sarcomas

NCT03277924

Conditions
Bone Diseases, Bone Neoplasms, Bone Sarcoma, +27 more
Locations
  • Istituto Ortopedico Rizzoli Bologna, Italy
  • Candiolo Cancer Institute - FPO, IRCCS Candiolo, Italy
  • Istituto Nazionale dei Tumori Milan, Italy
  • Hospital Universitario Fundación Jiménez Díaz Madrid, Spain
View all 13 locations
View Trial Details

Related conditions